223 related articles for article (PubMed ID: 36401762)
21. Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice.
Nakagawa T; Furukawa Y; Hayashi T; Nomura A; Yokoe S; Moriwaki K; Kato R; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M
Hypertens Res; 2019 Dec; 42(12):1858-1871. PubMed ID: 31409917
[TBL] [Abstract][Full Text] [Related]
22. Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy.
Zeng P; Lu W; Tian J; Qiao S; Li J; Glorieux C; Wen S; Zhang H; Li Y; Huang P
J Hematol Oncol; 2022 Mar; 15(1):30. PubMed ID: 35313945
[TBL] [Abstract][Full Text] [Related]
23. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
24. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway.
Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L
Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361
[TBL] [Abstract][Full Text] [Related]
25. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.
Cao B; Duan M; Xing Y; Liu C; Yang F; Li Y; Yang T; Wei Y; Gao Q; Jiang J
J Cell Mol Med; 2019 Apr; 23(4):2384-2398. PubMed ID: 30677218
[TBL] [Abstract][Full Text] [Related]
26. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.
Tang W; Su G; Li J; Liao J; Chen S; Huang C; Liu F; Chen Q; Ye Y
Int J Oncol; 2014 Sep; 45(3):995-1010. PubMed ID: 24968890
[TBL] [Abstract][Full Text] [Related]
27. Correction to: IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression.
He X; Wu N; Li R; Zhang H; Zhao Y; Nie Y; Wu J
Cell Oncol (Dordr); 2023 Feb; 46(1):165-166. PubMed ID: 36574188
[No Abstract] [Full Text] [Related]
28. OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells.
Ge X; Peng X; Li M; Ji F; Chen J; Zhang D
Pathol Res Pract; 2021 Sep; 225():153580. PubMed ID: 34391182
[TBL] [Abstract][Full Text] [Related]
29. Augmented O-GlcNAcylation exacerbates right ventricular dysfunction and remodeling via enhancement of hypertrophy, mitophagy, and fibrosis in mice exposed to long-term intermittent hypoxia.
Yokoe S; Hayashi T; Nakagawa T; Kato R; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M
Hypertens Res; 2023 Mar; 46(3):667-678. PubMed ID: 36376492
[TBL] [Abstract][Full Text] [Related]
30. Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer.
Qiao S; Lu W; Glorieux C; Li J; Zeng P; Meng N; Zhang H; Wen S; Huang P
Oncogene; 2021 Sep; 40(39):5880-5892. PubMed ID: 34349242
[TBL] [Abstract][Full Text] [Related]
31. PKA and cAMP stimulate proliferation of mouse embryonic stem cells by elevating GLUT1 expression mediated by the NF-κB and CREB/CBP signaling pathways.
Kim MO; Lee YJ; Park JH; Ryu JM; Yun SP; Han HJ
Biochim Biophys Acta; 2012 Oct; 1820(10):1636-46. PubMed ID: 22658979
[TBL] [Abstract][Full Text] [Related]
32. Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism.
Li H; Li JJ; Lu W; Yang J; Xia Y; Huang P
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831011
[TBL] [Abstract][Full Text] [Related]
33. UBXN11 Predicts as a Poor Index for Colorectal Cancer and Contributes to the Tumorigenesis by Activating NF-κB Signaling.
Chen X; Chen C; He R; Huang Y; Wang Y
Dig Dis Sci; 2024 Jun; 69(6):2074-2082. PubMed ID: 38622461
[TBL] [Abstract][Full Text] [Related]
34. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
35. NF-κB-induced WIP1 expression promotes colorectal cancer cell proliferation through mTOR signaling.
Bai F; Zhou H; Fu Z; Xie J; Hu Y; Nie S
Biomed Pharmacother; 2018 Mar; 99():402-410. PubMed ID: 29367109
[TBL] [Abstract][Full Text] [Related]
36. Baicalin triggers apoptosis, inhibits migration, and enhances anti-tumor immunity in colorectal cancer via TLR4/NF-κB signaling pathway.
Song L; Zhu S; Liu C; Zhang Q; Liang X
J Food Biochem; 2022 Mar; 46(3):e13703. PubMed ID: 33742464
[TBL] [Abstract][Full Text] [Related]
37. KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation.
Li H; Lan J; Wang G; Guo K; Han C; Li X; Hu J; Cao Z; Luo X
J Exp Clin Cancer Res; 2020 Jan; 39(1):12. PubMed ID: 31931846
[TBL] [Abstract][Full Text] [Related]
38. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
[TBL] [Abstract][Full Text] [Related]
39. Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation.
Zhang D; Zhang JW; Xu H; Chen X; Gao Y; Jiang HG; Wang Y; Wu H; Yang L; Wang WB; Dai J; Xia L; Peng J; Zhou FX
Mol Cancer; 2024 Apr; 23(1):70. PubMed ID: 38576002
[TBL] [Abstract][Full Text] [Related]
40. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
Yi W; Xiao E; Ding R; Luo P; Yang Y
Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
